The Digestive Diseases and Microbiota group of the Girona Biomedical Research Institute (IDIBGI), linked to the Digestology Service of the Hospital Trueta, has observed a prebiotic effect of bread made following traditional processes in patients with ulcerative colitis (UC) in remission and symptoms of irritable bowel syndrome (IBS).

There is now no doubt about the impact of the gut microbiota on digestive diseases such as UC and IBS. In recent years, much effort has been devoted to finding treatments based on modulating the microbiota to help improve digestive symptoms. In this sense, prebiotics are foods that selectively stimulate the growth of microorganisms present in the host (i.e. us), which have a health benefit.

The study, published in the scientific journal PLOS ONE, included 31 UC patients in remission who were experiencing IBS-like symptoms. These patients were randomly assigned to a dietary intervention with 200 grams of traditional or control bread per day for a period of 8 weeks. The results indicate a reduction in IBS-associated symptomatology (i.e. abdominal pain) and a potential alteration of the gut microbiota by reducing the ratio of Firmicutes/Bacteroidetes bacteria, a parameter indicative of microbial disturbance. These results have opened up new perspectives on the use of bread as a potential prebiotic agent.

This work comes from a collaboration within the RETOS-Colaboración programme of the Ministry of Economy, Industry and Competitiveness (RTC-2017-6467-2), of which the Institute of Biomedical Research of Girona (IDIBGI), the Hospital del Mar Institute of Medical Research (IMIM), and the bakery company Elias Boulanger S.L. are part of.

Reference article: Lluansí A, Llirós M, Carreras-Torres R, Bahí A, Capdevila M, Feliu A, Vilà-Quintana L, Elias-Masiques N, Cueva E, Peries L, Torrealba L, Miquel-Cusachs JO, Sàbat M, Busquets D, López C, Delgado-Aros S, Garcia-Gil LJ, Elias I, Aldeguer X. Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study. PLoS One. 2024 Feb 16;19(2):e0297836. doi: 10.1371/journal.pone.0297836. PMID: 38363772; PMCID: PMC10871487.

Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un ensayo de microscopía dinámica del ...

by CSIC - Centro Superior de Investigaciones Científicas

La revista ‘Nature Protocols’ selecciona esta técnica como “pro...

Photos Stream